• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • Published: December 2013
  • Region: Global
  • 157 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • AB SCIEX LLC
  • Abbott Laboratories
  • Agilent Technologies
  • Biomedical Diagnostics
  • bioMerieux
  • DiaSorin S.p.A
  • MORE

'Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'

Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests.

The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting deficiency (hyposecretion) or excess (hypersecretion) secretions of these READ MORE >

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.3.1.3 Models
1.3.1.4 Assumptions
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Endocrine Testing Market (2012 & 2019)
2.2 Global Endocrine Testing Market, by Test, 2012 (USD Million)
2.3 Global Endocrine Testing Market, by Diagnostic Technologies, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Overview
3.1.1 Introduction to Elements of Endocrine System
3.1.2 Market Potential of Endocrine Testing Market
3.1.3 Future Scenario of Endocrine Testing Market
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Increasing Incidence of diabetic and obese population worldwide
3.2.1.2 Consistent rise in geriatric population Worldwide
3.2.1.3 Technological advancements
3.2.2 Market Restraints
3.2.2.1 High cost of technology
3.2.2.2 Lack of healthcare awareness in emerging economies
3.2.3 Market Opportunity
3.2.3.1 Investment opportunity
3.3 Porter’s Five Force Analysis for the Global Endocrine Testing Market
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of substitutes
3.3.4 Threat of new entrants
3.3.5 Competitive rivalry
3.1 Market Attractiveness Analysis: Global Endocrine Technologies Market, by Geography

Chapter 4 Endocrine Testing Market, by Test
4.1 Overview
4.1.1 Global Endocrine Testing Market, by Test, 2011 – 2019 (USD Million)
4.2 Estradiol (E2) Test
4.2.1 Global Estradiol (E2) Test Market, 2011 – 2019 (USD Million)
4.3 Follicle Stimulating Hormone (FSH) Test
4.3.1 Global Follicle Stimulating Hormone (FSH) Test Market, 2011 – 2019 (USD Million)
4.4 Human Chorionic Gonadotropin (hCG) Test
4.4.1 Global Human Chorionic Gonadotropin (hCG) Test Market, 2011 – 2019 (USD Million)
4.5 Luteinizing Hormone (LH) Test
4.5.1 Global Luteinizing Hormone (LH) Test Market, 2011 – 2019 (USD Million)
4.6 Dehydroepiandrosterone Sulfate (DHEAS) Test
4.6.1 Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market, 2011 – 2019 (USD Million)
4.7 Progesterone Test
4.7.1 Global Progesterone Test Market, 2011 – 2019 (USD Million)
4.8 Testosterone Test
4.8.1 Global Testosterone Test Market, 2011 – 2019 (USD Million)
4.9 Thyroid Stimulating Hormone (TSH) Test
4.9.1 Global Thyroid Stimulating Hormone (TSH) Test Market, 2011 – 2019 (USD Million)
4.10 Prolactin Test
4.10.1 Global Prolactin Test Market, 2011 – 2019 (USD Million)
4.11 Cortisol Test
4.11.1 Global Cortisol Test Market, 2011 – 2019 (USD Million)
4.12 Insulin Test
4.12.1 Global Insulin Test Market, 2011 – 2019 (USD Million)
4.13 Others
4.13.1 Global Others Market, 2011 – 2019 (USD Million)

Chapter 5 Endocrine Testing Market, by Diagnostic Technologies
5.1 Overview
5.1.1 Global Endocrine Testing Market, by Diagnostic Technologies 2011 – 2019 (USD Million)
5.2 Tandem Mass Spectrometry
5.2.1 Global Tandem Mass Spectrometry Market, 2011 – 2019 (USD Million)
5.3 Immunoassay (Enzyme Linked Assays(EIA), Radio Immunoassay (RIA))Technologies
5.3.1 Global Immunoassay Technologies Market, 2011 – 2019 (USD Million)
5.4 Monoclonal and Polyclonal Antibody Technologies
5.4.1 Global Monoclonal and Polyclonal Antibody Technologies Market, 2011 – 2019 (USD Million)
5.5 Sensor Technologies
5.5.1 Global Sensor Technologies Market, 2011 – 2019 (USD Million)
5.6 Clinical Chemistry Technologies
5.6.1 Global Clinical Chemistry Technologies Market, 2011 – 2019 (USD Million)
5.7 Others ((Liquid Chromatography + Tandem Mass Spectrometry (LC-MS/MS), High performance Liquid Chromatography (HPLC), etc.)
5.7.1 Global Others Market, 2011 – 2019 (USD Million)

Chapter 6 Endocrine Testing Market, by End Users
6.1 Overview
6.1.1 Global Endocrine Testing Market, by End Users 2011 – 2019 (USD Million)
6.2 Hospitals
6.2.1 Global Hospitals Market, 2011 – 2019 (USD Million)
6.3 Commercial Laboratories
6.3.1 Global Commercial Laboratories Market, 2011 – 2019 (USD Million)
6.4 Ambulatory Care Centers
6.4.1 Global Ambulatory Care Centers Market, 2011 – 2019 (USD Million)
6.5 Home Based Tests
6.5.1 Global Home Based Tests Market, 2011 – 2019 (USD Million)
6.6 Physician Offices
6.6.1 Global Physician Offices Market, 2011 – 2019 (USD Million)

Chapter 7 Endocrine Testing Market, by Geography
7.1 Overview
7.1.1 Global Endocrine Testing Market, by Geography 2011 – 2019 (USD Million)
7.2 North America
7.2.1 North America Endocrine Testing Market, 2011 – 2019 (USD Million)
7.3 Europe
7.3.1 Europe Endocrine Testing Market, 2011 – 2019 (USD Million)
7.4 Asia-Pacific
7.4.1 Asia-Pacific Endocrine Testing Market, 2011 – 2019 (USD Million)
7.5 Rest of the World (RoW)
7.5.1 RoW Endocrine Testing Market, 2011 – 2019 (USD Million)

Chapter 8 Competitive Landscape
8.1 Market Share by Key Players: Global Endocrine Testing Market, 2012 (%)
8.1.1 Global Endocrine Testing Market Share Analysis, by Key Players, 2012 (%)

Chapter 9 Recommendations
9.1 Market strategies for success
9.2 Barriers to be considered

Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.1.5 Recent Developments
10.2 AB SCIEX LLC
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Product Portfolio
10.2.4 Business Strategies
10.2.5 Recent Developments
10.3 Agilent Technologies
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Product Portfolio
10.3.4 Business Strategies
10.3.5 Recent Developments
10.4 Biomedical Diagnostics
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Product Portfolio
10.4.4 Business Strategies
10.4.5 Recent Developments
10.5 bioMerieux
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Product Portfolio
10.5.4 Business Strategies
10.5.5 Recent Developments
10.6 Bio-Rad Laboratories, Inc.
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Product Portfolio
10.6.4 Business Strategies
10.6.5 Recent Developments
10.7 DiaSorin S.p.A
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Product Portfolio
10.7.4 Business Strategies
10.7.5 Recent Developments
10.8 F. Hoffmann-La Roche Ltd.
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Product Portfolio
10.8.4 Business Strategies
10.8.5 Recent Developments
10.9 Laboratory Corporation of America Holdings (LabCorp)
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Product Portfolio
10.9.4 Business Strategies
10.9.5 Recent Developments
10.10 Ortho Clinical Diagnostics
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Product Portfolio
10.10.4 Business Strategies
10.10.5 Recent Developments
10.11 Quest Diagnostics
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Product Portfolio
10.11.4 Business Strategies
10.11.5 Recent Developments
10.12 Siemens Healthcare
10.12.1 Company Overview
10.12.2 Financial Overview
10.12.3 Product Portfolio
10.12.4 Business Strategies
10.12.5 Recent Developments
10.13 Sysmex Corporation
10.13.1 Company Overview
10.13.2 Financial Overview
10.13.3 Product Portfolio
10.13.4 Business Strategies
10.13.5 Recent Developments
10.14 Thermo Fisher Scientific
10.14.1 Company Overview
10.14.2 Financial Overview
10.14.3 Product Portfolio
10.14.4 Business Strategies
10.14.5 Recent Developments

List of Figures

FIG. 1 Endocrine Testing: Market Segmentation
FIG. 2 Global Endocrine Testing Market, by Test, 2012 (USD Million)
FIG. 3 Global Endocrine Testing Market, by Diagnostic Technology, 2012 (USD Million)
FIG. 4 Introduction to Endocrine Glands/organs
FIG. 5 Global Rate of Aging Population
FIG. 6 Porter’s Five Forces Analysis: Global Endocrine Testing Market
FIG. 7 Market Attractiveness Analysis: Global Endocrine Testing Market, by Geography
FIG. 8 Global Estradiol (E2) Test Market, 2011 – 2019 (USD Million)
FIG. 9 Global Follicle Stimulating Hormone (FSH) Test Market, 2011 - 2019 (USD Million)
FIG. 10 Global Human Chorionic Gonadotropin (hCG) Test Market, 2011 - 2019 (USD Million)
FIG. 11 Global Luteinizing Hormone (LH) Test Market, 2011 - 2019 (USD Million)
FIG. 12 Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market, 2011 - 2019 (USD Million)
FIG. 13 Global Progesterone Test Market, 2011 - 2019 (USD Million)
FIG. 14 Global Testosterone Test Market, 2011 - 2019 (USD Million)
FIG. 15 Global Thyroid Stimulating Hormone (TSH) Test Market, 2011 - 2019 (USD Million)
FIG. 16 Global Prolactin Test Market, 2011 - 2019 (USD Million)
FIG. 17 Global Cortisol Test Market, 2011 - 2019 (USD Million)
FIG. 18 Global Insulin Test Market, 2011 - 2019 (USD Million)
FIG. 19 Global Others Market, 2011 - 2019 (USD Million)
FIG. 20 Global Tandem Mass Spectrometry Market, 2011 - 2019 (USD Million)
FIG. 21 Global Immunoassay Technologies Market, 2011 - 2019 (USD Million)
FIG. 22 Global Monoclonal and Polyclonal Antibody Technologies Market, 2011 - 2019 (USD Million)
FIG. 23 Global Sensor Technologies Market, 2011 - 2019 (USD Million)
FIG. 24 Global Clinical Chemistry Technologies Market, 2011 - 2019 (USD Million)
FIG. 25 Global Others Market, 2011 - 2019 (USD Million)
FIG. 26 Global Hospitals Market, 2011 - 2019 (USD Million)
FIG. 27 Global Commercial Laboratories Market, 2011 - 2019 (USD Million)
FIG. 28 Global Ambulatory Care Centers Market, 2011 - 2019 (USD Million)
FIG. 29 Global Home Based Tests Market, 2011 - 2019 (USD Million)
FIG. 30 Global Physician Offices Market, 2011 - 2019 (USD Million)
FIG. 31 North America Endocrine Testing Market, 2011 - 2019 (USD Million)
FIG. 32 Europe Endocrine Testing Market, 2011 - 2019 (USD Million)
FIG. 33 Asia-Pacific Endocrine Testing Market, 2011 - 2019 (USD Million)
FIG. 34 RoW Endocrine Testing Market, 2011 - 2019 (USD Million)
FIG. 35 Endocrine Testing: Market Share, by Key Players, 2012 (%)
FIG. 36 Abbott Laboratories, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 37 Agilent Technologies, Annual Revenue: 2010 – 2012 (USD million,)
FIG. 38 bioMerieux, Annual Sales Revenue: 2010 – 2012 (USD Million) Conversion Rate 1Euro = 1.34 USD
FIG. 39 Bio-Rad, Annual Sales Revenue : 2010 – 2012 (USD Million)
FIG. 40 DiaSorin, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 41 F. Hoffmann-La Roche Ltd.: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 42 LabCorp: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 43 Ortho Clinical Diagnostics, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 44 Quest Diagnostics, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 45 Siemens Healthcare, Annual Revenue: 2010 – 2012 (USD Billion)
FIG. 46 Sysmex Corporation, Annual Sales: 2011 – 2013 (USD million)
FIG. 47 Thermo Fisher Scientific, Annual Revenue: 2010 – 2012 (USD million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Endocrine Testing Market (2012 & 2019)
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 Global Endocrine Testing Market, by Test, 2011 – 2019 (USD Million)
TABLE 6 Estradiol Test Result Range
TABLE 7 The Reasons For Performing FSH Test
TABLE 8 Progesterone Test Result Range
TABLE 9 Global Endocrine Testing Market, by Diagnostic Technologies 2011 – 2019 (USD Million)
TABLE 10 Global Endocrine Testing Market, by Ed Users 2011 – 2019 (USD Million)
TABLE 11 Global Endocrine Testing Market, by Geography 2011 – 2019 (USD Million)

Endocrine glands and hormones are major elements of the endocrine system that are crucial for regulation of several body mechanisms such as growth, development and homeostasis. Responses to stress, injury, absorption of nutrients maintenance of water and electrolyte balance and energy metabolism constitutes major areas of control and integration offered by the endocrine system. There are endocrine glands (pituitary, pineal, thyroid and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream. These glands have rich blood supply which facilitate movement of hormones to reach their target organs and enable various alterations in metabolism of target organs by increasing or decreasing their activity.

Endocrine tests are crucial for monitoring normal functioning of endocrine system since any deviation (hypersecretion or hyposecretion) from the normal levels of hormones results in development of various endocrine disorders such as diabetes, thyroid, cancer and infertility. These tests enable both qualitative and quantitative determination of the hormone levels and can be performed either in hospitals, commercial laboratories (thyroid hormone tests, progesterone tests) or even at home (pregnancy test kit, blood sugar test strips). Endocrine testing market is witnessing increasing growth and adoption majorly due to constant rise in several disorders such as diabetes, thyroid and reproductive system disorders.These disorders indicate the abnormal level of endocrine hormones in the body thereby creating a need and demand for effective endocrine testing kits. In addition, continuous evolution of diagnostic platforms followed by increasing healthcare awareness would further augment the growth and development of endocrine testing platforms. The global market for endocrine testing market was valued at USD 1,537.5 million in 2012 growing at a CAGR of 4.3% from 2013 to 2019.

Endocrine testing market can be analyzed by the type of tests involved, diagnostic platforms and end users. The various hormone tests refer to estradiol, Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing Hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Testosterone, Thyroid Stimulating Hormone (TSH), Prolactin, Cortisol, Insulin tests and others. Thyroid stimulating hormone test market was estimated to be the largest market segment in 2012 growing at a CAGR of 5.4% during the forecast period. This is attributed to high prevalence of thyroid disorders among geriatric population and also is more common in females than males with a female to male ratio of 10:1. Also, as per the research findings published in Elsevier, Inc., among the population aged above 65, 1.7% have hypothyroidism and 13.7% of aging population have subclinical hypothyroidism. Insulin test is expected to be the fastest growing segment during the forecast period from 2013 to 2019. The major reason being constant rise in diabetic and obese population across the globe.

According to World Health Organization (WHO), diabetes is predicted to become the seventh leading cause of death by 2030 worldwide and around 80% of diabetes deaths occur in low and middle income nations due to poor management of the disease. However, efforts have been undertaken to increase the awareness about diabetes, International Diabetes Federation (IDF) and WHO declared November 14 as World Diabetes Day and the theme for 2013 was “Prevent diabetes and protect our future”. Such initiatives will ensure awareness about proper management of diabetes thereby facilitating growth and development of endocrine testing market.

Novel and innovative diagnostic technologies enhance the growth and uptake of several endocrine tests. Immunoassays, clinical chemistry, sensor, tandem mass spectrometry and antibody technologies are the most popular technological platforms employed for performing several endocrine tests. Factors such as consistent innovation in diagnostic technologies followed by enhanced capabilities (high precision, sensitivity and accuracy) and low susceptibility for errors encourages further growth and development of efficient technology platforms. Use of tandem mass spectrometry will witness commendable growth as this platform enables an accurate measurement of even small quantities of hormone levels from the biological samples. Tandem mass spectrometry segment is estimated to be the fastest growing diagnostic technology segment during the forecast period. Moreover, immunoassays and sensor technologies market recorded second and third highest growth rate, respectively, during the forecast period. Several end users represent hospitals, laboratories, ambulatory care centers, home based tests and others that facilitate endocrine testing. Increasing preference of the customers towards instant test results followed by low cost supports the growth and adoption of ambulatory care centers and home based test kits over the others (hospitals, laboratories).

Geographically, Europe accounts for the largest percentage share of the global endocrine testing market accounting for more than 28% of the total market in 2012. This is justified by the presence of technologically updated infrastructure and well trained healthcare professionals in this region compared to the other regions. In addition, consistent rise in awareness levels in patient population has further augmented growth and development of endocrine testing kits in this region. Also, as per the data enumerated by Organization for Economic Co-operation and Development (OECD) Library, in the year 2012, more than 52% of adult population is overweight or obese and is prevalent in around 18 out of 27 European Union member nations. These statistics further accentuate the growth and uptake of several endocrine tests in this region. Asia-Pacific region is anticipated to record a high growth rate owing to increased participation of the respective governments in improving the overall healthcare sector and tapping huge untapped potential in these regions. In addition, rise in disposable income and increased preference of the population to avail technologically advanced medical solutions will further support the growth of endocrine testing market. North America is also expected to exhibit considerable growth rate majorly due to increased acceptance towards novel approaches and consistent improvements in healthcare facilities in this region.

- Abbott Laboratories
- AB SCIEX LLC
- Agilent Technologies
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A
- F. Hoffmann-La Roche Ltd.
- Laboratory Corporation of America Holdings (LabCorp)
- Ortho Clinical Diagnostics
- Quest Diagnostics
- Siemens Healthcare
- Sysmex Corporation
- Thermo Fisher Scientific

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos